Spero closes $30M series B round

By BC Staff | Feb 3, 2016 | 3:08 AM GMT

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) secured $30 million in a tranched series

Read the full 140 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE